Sarah Will

1.2k citations

28 papers · 626 indexed · h-index 15

Impact in

Endocrinology, Diabetes and Metabolism top 5%
- Diabetes Treatment and Management
- Diet, Metabolism, and Disease
Endocrine and Autonomic Systems top 10%
- Regulation of Appetite and Obesity

Papers in ⓘ

Endocrinology, Diabetes and Metabolism 13
- Diabetes Treatment and Management 9
- Diet, Metabolism, and Disease 2
Endocrine and Autonomic Systems 5
- Regulation of Appetite and Obesity 5

Co-authors: Mylène Perreault (5 shared papers)James L. Trevaskis (8 shared papers)Stephanie Oldham (7 shared papers)James F. Tobin (3 shared papers)Steven J. Kirincich (2 shared papers)David V. Erbe (1 shared paper)Vipin Suri (1 shared paper)Yanling Zhang (1 shared paper)
Journals: Molecular Metabolism (4 papers)Diabetes (3 papers)Endocrinology (2 papers)Pharmaceutics (2 papers)Diabetes Obesity and Metabolism (2 papers)
Partner nations: United States United Kingdom Canada

In The Last Decade

Sarah Will

26 papers receiving 611 citations

Peers

Countries citing papers authored by Sarah Will

Since Specialization

Citations

This map shows the geographic impact of Sarah Will's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Will with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Will more than expected).

Fields of papers citing papers by Sarah Will

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Will. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Will. The network helps show where Sarah Will may publish in the future.

Co-authors

The 25 scholars most cited alongside Sarah Will, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sarah Will Line = papers co-authored together Sarah Will links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Molecular activation of PPARγ by angiotensin II type 1-receptor antagonists Vascular Pharmacology ·David V. Erbe, Katherine Gartrell, Yanling Zhang, Vipin Suri, Steven J. Kirincich, Sarah Will, Mylène Perreault, Suyue Wang, James F. Tobin	2006	122
2	Development of an orally delivered GLP-1 receptor agonist through peptide engineering and drug delivery to treat chronic disease Scientific Reports ·Sergei Pechenov, Jefferson D. Revell, Sarah Will, Jacqueline Naylor, Puneet Tyagi, Chandresh Patel, Lihuan Liang, Leo Tseng, Yue Huang, Anton I. Rosenbaum, Kemal Balic, Anish Konkar, Joseph Grimsby, J. Anand Subramony	2021	55
3	Strength training does not improve lipoprotein-lipid profiles in men at risk for CHD Medicine & Science in Sports & Exercise ·Peter Kokkinos, B. F. Hurley, M. A. Smutok, Charles M. Farmer, Christine Reece, R S Shulman, C. Charabogos, Julie A. Patterson, Sarah Will, J. DeVane-Bell, A. P. Goldberg	1991	55
4	Disruption of G Protein-Coupled Receptor 39 Impairs Insulin Secretion in Vivo Endocrinology ·Frédéric Tremblay, Ann-Marie Richard, Sarah Will, Jameel Syed, Nancy Stedman, Mylène Perreault, Ruth E. Gimeno	2009	53
5	Superior reductions in hepatic steatosis and fibrosis with co-administration of a glucagon-like peptide-1 receptor agonist and obeticholic acid in mice Molecular Metabolism ·Hani Jouihan, Sarah Will, Silvia Guionaud, Michelle L. Boland, Stephanie Oldham, Peter Ravn, Anthony Celeste, James L. Trevaskis	2017	49
6	Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction World Journal of Gastroenterology ·Michelle L. Boland, Stephanie Oldham, Brandon B. Boland, Sarah Will, Jean‐Martin Lapointe, Silvia Guionaud, Christopher J. Rhodes, James L. Trevaskis	2018	46
7	Targeted mutations induced by a single acetylaminofluorene DNA adduct in mammalian cells and bacteria. Proceedings of the National Academy of Sciences ·Masaaki Moriya, Masaru Takeshita, F. E. A. Johnson, Keith Peden, Sarah Will, Arthur P. Grollman	1988	39
8	A GLP-1:CCK fusion peptide harnesses the synergistic effects on metabolism of CCK-1 and GLP-1 receptor agonism in mice Appetite ·David C. Hornigold, Emma Roth, Victor Howard, Sarah Will, Stephanie Oldham, Matthew P. Coghlan, Clémence Blouet, James L. Trevaskis	2018	31
9	Combined loss of GLP-1R and Y2R does not alter progression of high-fat diet-induced obesity or response to RYGB surgery in mice Molecular Metabolism ·Brandon B. Boland, Michael B. Mumphrey, Hao Zheng, R. Leigh Townsend, Benji Gill, Stephanie Oldham, Sarah Will, Christopher D. Morrison, Sangho Yu, Heike Münzberg, Christopher J. Rhodes, James L. Trevaskis, Hans‐Rudolf Berthoud	2019	28
10	Activation of TrkB with TAM-163 Results in Opposite Effects on Body Weight in Rodents and Non-Human Primates PLoS ONE ·Mylène Perreault, Feng Guo, Sarah Will, Tiffany Gareski, David Kubasiak, Kimberly Marquette, Yulia Vugmeyster, Thaddeus J. Unger, Juli E. Jones, Ariful Qadri, Seung Hahm, Ying Sun, Cynthia M. Rohde, Raphael Zwijnenberg, Janet Paulsen, Ruth E. Gimeno	2013	21
11	Prodrug delivery of novel PTP1B inhibitors to enhance insulin signalling Diabetes Obesity and Metabolism ·D.V. Erbe, Lori D. Klaman, Douglas Wilson, Z. Wan, Steven J. Kirincich, Sarah Will, Xin Xu, Leslie Kung, S. Wang, Steve Tam, JULIE J.H. LEE, James F. Tobin	2009	17
12	Loss of Coiled-Coil Domain Containing 80 Negatively Modulates Glucose Homeostasis in Diet-Induced Obese Mice Endocrinology ·Frédéric Tremblay, Christine Huard, Jessie Dow, Tiffany Gareski, Sarah Will, Ann-Marie Richard, Jameel Syed, Steven A. Bailey, Karrie A. Brenneman, Robert V. Martinez, Mylène Perreault, Qingcong Lin, Ruth E. Gimeno	2012	16
13	NO: possible role in TTX-sensitive field-stimulated relaxations of the rat oesophageal tunica muscularis mucosae? European Journal of Pharmacology ·Sarah Will, D. Bieger, Chris R. Triggle	1990	15
14	Specific loss of GIPR signaling in GABAergic neurons enhances GLP-1R agonist-induced body weight loss Molecular Metabolism ·Jordan Wean, Allison H. Kowalsky, Rhianna C. Laker, Sarah Will, Daniel J. Drucker, Christopher J. Rhodes, Randy J. Seeley	2024	14
15	Hepatic glucagon action: beyond glucose mobilization Physiological Reviews ·Sarina Kajani, Rhianna C. Laker, Ekaterina L. Ratkova, Sarah Will, Christopher J. Rhodes	2024	14
16	Behavioural and neurochemical mechanisms underpinning the feeding-suppressive effect of GLP-1/CCK combinatorial therapy Molecular Metabolism ·Emma Roth, Simon Benoit, Baptiste Quentin, Brian Lam, Sarah Will, Marcella Ma, Nick Heeley, Tamana Darwish, Yashaswi Shrestha, Fiona M. Gribble, Frank Reimann, Irina Pshenichnaya, Giles S.H. Yeo, David Baker, James L. Trevaskis, Clémence Blouet	2020	12
17	Gut check on diabesity: leveraging gut mechanisms for the treatment of type 2 diabetes and obesity Current Opinion in Pharmacology ·Sarah Will, David C. Hornigold, David Baker, Matthew P. Coghlan, Malcolm Mesquita, James L. Trevaskis, Jacqueline Naylor	2017	11
18	Modulation of nutrient sensing nuclear hormone receptors promotes weight loss through appetite suppression in mice Diabetes Obesity and Metabolism ·Mylène Perreault, Sarah Will, Darrell Panza, Tiffany Gareski, Kimberly Harding, David Kubasiak, Mary Jalenak, Katherine Gartrell, S. Wang, Gideon Bollag, David Artis, Prabha N. Ibrahim, Patrick Womack, Jack J. Lin, Eddine Saiah, Tahani Salman M Al Mansour, G P Vlasuk, D.V. Erbe, James F. Tobin	2009	10
19	Systems Biology and Peptide Engineering to Overcome Absorption Barriers for Oral Peptide Delivery: Dosage Form Optimization Case Study Preceding Clinical Translation Pharmaceutics ·Puneet Tyagi, Chandresh Patel, Kimberly Gibson, Fiona MacDougall, Sergei Pechenov, Sarah Will, Jefferson D. Revell, Yue Huang, Anton I. Rosenbaum, Kemal Balic, Umar S. M. Maharoof, Joseph Grimsby, J. Anand Subramony	2023	6
20	The prevalence and prognostic value of systemic inflammation in good performance status patients with advanced, inoperable non‐small cell lung cancer receiving palliative radiotherapy: Comparison of composite ratios and cumulative scores Cancer Medicine ·Josh McGovern, Fraser O'Rourke, Sarah Will, Hanh Thi Ngoc Nguyen, Elise Cranfield, C Maseland, Nicholas MacLeod, John D. Maclay, Barry Laird, Ross D. Dolan, Donald C. McMillan	2024	3

About Sarah Will

Sarah Will is a scholar working on Endocrinology, Diabetes and Metabolism, Endocrine and Autonomic Systems, Pharmaceutical Science, Physiology and Internal Medicine, having authored 28 papers that have together received 626 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (9 papers), Pancreatic function and diabetes (6 papers), Metabolism, Diabetes, and Cancer (5 papers), Regulation of Appetite and Obesity (5 papers), Neuropeptides and Animal Physiology (4 papers), Adipose Tissue and Metabolism (4 papers), Diet and metabolism studies (3 papers) and Diet, Metabolism, and Disease (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (200 citations), Endocrine and Autonomic Systems (64 citations), Physiology (163 citations), Pharmaceutical Science (25 citations) and Cellular and Molecular Neuroscience (71 citations). Sarah Will has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Mylène Perreault, James L. Trevaskis, Stephanie Oldham, James F. Tobin, Steven J. Kirincich, David V. Erbe, Vipin Suri, Yanling Zhang, Suyue Wang and Christopher J. Rhodes. Their work appears in journals such as Molecular Metabolism, Diabetes, Endocrinology, Pharmaceutics and Diabetes Obesity and Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact